153
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Activated platelet chemiluminescence and presence of CD45+ platelets in patients with acute myocardial infarction

, , , , , & show all
Pages 405-408 | Received 01 Jun 2013, Accepted 23 Jul 2013, Published online: 08 Oct 2013
 

Abstract

It has been found that in 15% of acute myocardial infarction patients’ platelets generate reactive oxygen species that can be detected with luminol-enhanced chemiluminescence of platelet-rich plasma within 8–10 days after acute myocardial infarction. This increase in generate reactive oxygen species production coincides with the emergence of CD45+ platelets. The ability of platelets to carry surface leukocyte antigen implies their participation in exchange of specific proteins in the course of acute myocardial infarction. Future studies of CD45+ platelets in peripheral blood of acute myocardial infarction patients in association with generate reactive oxygen species production may provide a new insight into the complex mechanisms of cell–cell interactions associated with acute myocardial infarction.

Acknowledgements

The authors are grateful to Dr Leonid Margolis for his constructive criticism. We are grateful to Dr Alexey Yavlinsky and Dr Barry Alpher for assistance in editing and improving the English style.

Notice of correction:

Following initial Early Online publication, grant numbers were added by request of the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.